Retinoic Acid, X and Orphans Receptors

KCL-286 View larger

KCL-286

AT78575

CAS 1952276-71-9

More details

Molarity Calculation Cart®

HOW TO ORDER

$407.00

$407.00 per mg

Quantity Discount Table - Order More To Get More Price Discount

QuantitymgUnit Price ($/mg or $/Unit)Final Price
1100 $183.15 Total: $18,315.00
150 $211.64 Total: $10,582.00
125 $248.27 Total: $6,206.75
110 $293.04 Total: $2,930.40
15 $345.95 Total: $1,729.75

Data sheet

Molecular FormulaC19H14N2O4
Molecular Weight334.33
CAS Numbers1952276-71-9
Storage Condition0C Short Term, -20C Long Term
SolubilityDMSO
Purity98% by HPLC
SMILES CodeO=C(O)C=1C=CC(=CC1)C2=NOC(=N2)C=3OC=4C(C3)=C(C=CC4C)C
ReferencesGoncalves MB, et al. Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL-286, a novel retinoic acid receptor-? agonist for treatment of spinal cord injury, in male healthy participants. Br J Clin Pharmacol. 2023 Jul 15.

More info

KCL-286 is an orally available and potent retinoic acid receptor beta agonist for the amelioration of spinal cord injury (SCI).